跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,010 条关于
“EyePoint, Inc.”
全部
41,010
临床试验
11,274
药物
1,602
机构
6,168
资讯
21,966
12天前
EyePoint's DURAVYU Misses Primary Endpoint in Phase 3 LUGANO Trial for Wet AMD
11个月前
EyePoint Pharmaceuticals Raises $150 Million to Advance DURAVYU Phase 3 Trials for Retinal Diseases
去年
EyePoint Pharmaceuticals Advances Wet AMD Treatment with Phase 3 Trials
去年
EyePoint Pharmaceuticals Doses First Patient in Phase 3 Trial of Duravyu for Wet AMD
去年
EyePoint's DURAVYU Shows Promise in Wet AMD and DME Trials, Anticipates Key Milestones in 2025
去年
EyePoint's DURAVYU Shows Promise in Phase 2 DME Trial
上个月
EyePoint Pharmaceuticals Advances Durability-Focused Phase 3 Trial Design for Retinal Disease
去年
EyePoint's DURAVYU Enters Phase 3 Trial for Wet AMD with First Patient Dosed in LUCIA Study
去年
EyePoint's Duravyu Shows Promise in Phase 2 Trial for Diabetic Macular Edema
去年
EyePoint's Duravyu Shows Promise in Phase 2 Trial for Diabetic Macular Edema
第 1 页,共 2197 页
上一页
下一页